Altimmune (ALT) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | 99.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.90% |
| Dec 31, 2025 | 99.87% |
| Sep 30, 2025 | 98.98% |
| Jun 30, 2025 | 99.68% |
| Mar 31, 2025 | 18.58% |
| Dec 31, 2024 | -47.91% |
| Sep 30, 2024 | -431.09% |
| Jun 30, 2024 | -197.05% |
| Mar 31, 2024 | -146.28% |
| Dec 31, 2023 | -13,421.66% |
| Sep 30, 2023 | -100.97% |
| Jun 30, 2023 | -2,769.47% |
| Mar 31, 2023 | -3,359.30% |
| Dec 31, 2022 | -67.38% |
| Sep 30, 2022 | 61.56% |
| Jun 30, 2022 | 72.24% |
| Mar 31, 2022 | 74.60% |
| Dec 31, 2021 | 107.03% |
| Sep 30, 2021 | 87.51% |
| Jun 30, 2021 | 79.70% |
| Mar 31, 2021 | 68.05% |
| Sep 30, 2020 | 45.99% |
| Jun 30, 2020 | -17.28% |
| Mar 31, 2020 | -23.18% |
| Sep 30, 2019 | -61,246.43% |
| Jun 30, 2019 | -67.76% |
| Mar 31, 2019 | 54.33% |
| Dec 31, 2018 | 96.52% |
| Sep 30, 2018 | 99.82% |
| Jun 30, 2018 | -6,753.69% |
| Mar 31, 2018 | -9,144.34% |
| Dec 31, 2017 | -979.33% |
| Sep 30, 2017 | -2,493.83% |
| Jun 30, 2017 | 75.22% |
| Mar 31, 2017 | 93.76% |
| Dec 31, 2016 | -270.18% |
| Sep 30, 2016 | -203.51% |
| Jun 30, 2016 | -12.58% |
| Mar 31, 2016 | -2,705.82% |
| Dec 31, 2015 | -118.08% |
| Sep 30, 2015 | -96.99% |
| Jun 30, 2015 | -615.31% |
| Dec 31, 2014 | -7.71% |
| Sep 30, 2014 | -139.05% |
| Jun 30, 2014 | -39.64% |
| Dec 31, 2013 | -432.84% |
| Sep 30, 2013 | -123.87% |
| Jun 30, 2013 | -13.12% |
| Mar 31, 2013 | 97.92% |
| Dec 31, 2012 | 84.00% |
| Sep 30, 2012 | 94.77% |
| Jun 30, 2012 | 93.55% |
| Mar 31, 2012 | -78.60% |
| Dec 31, 2011 | -3,222.90% |
| Sep 30, 2011 | -8,454.62% |
| Jun 30, 2011 | -3,279.62% |